Technical Analysis for HARP - Harpoon Therapeutics, Inc.

Grade Last Price % Change Price Change
F 8.75 0.57% 0.05
HARP closed up 0.57 percent on Friday, September 17, 2021, on 3.35 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical HARP trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
BB Squeeze Started Range Contraction 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.57%
Lower Bollinger Band Walk Weakness 0.57%
New 52 Week Low Weakness 0.57%
BB Squeeze Ended Range Expansion 0.57%
Older End-of-Day Signals for HARP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 22 hours ago
10 DMA Resistance about 22 hours ago
Rose Above 10 DMA about 22 hours ago
Up 1% about 22 hours ago
60 Minute Opening Range Breakout 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. It is involved in developing HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer; and HPN536 for the treatment of ovarian cancer and other mesothelin expressing tumors, as well as other products targeting tumor-associated antigens for the treatment of multiple myeloma and small-cell lung cancer. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Diseases Immune System Immunotherapy Oncology Cancer Immunotherapy Prostate Cancer Ovarian Cancer Small Cell Lung Cancer Tumors Multiple Myeloma Proteins Resistant Prostate Cancer Treatment Of Ovarian Cancer Mesothelin Metastatic Castration Resistant Prostate Cancer Neuvenge

Is HARP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.235
52 Week Low 8.22
Average Volume 483,858
200-Day Moving Average 16.55
50-Day Moving Average 10.04
20-Day Moving Average 9.05
10-Day Moving Average 8.80
Average True Range 0.51
ADX 27.79
+DI 15.07
-DI 24.57
Chandelier Exit (Long, 3 ATRs) 8.39
Chandelier Exit (Short, 3 ATRs) 9.76
Upper Bollinger Bands 9.73
Lower Bollinger Band 8.37
Percent B (%b) 0.28
BandWidth 14.98
MACD Line -0.40
MACD Signal Line -0.45
MACD Histogram 0.0501
Fundamentals Value
Market Cap 222.08 Million
Num Shares 25.4 Million
EPS -4.05
Price-to-Earnings (P/E) Ratio -2.16
Price-to-Sales 26.94
Price-to-Book 5.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.61
Resistance 3 (R3) 9.59 9.28 9.46
Resistance 2 (R2) 9.28 9.07 9.29 9.41
Resistance 1 (R1) 9.02 8.93 9.15 9.04 9.37
Pivot Point 8.71 8.71 8.78 8.72 8.71
Support 1 (S1) 8.45 8.50 8.58 8.47 8.13
Support 2 (S2) 8.14 8.36 8.15 8.09
Support 3 (S3) 7.88 8.14 8.04
Support 4 (S4) 7.90